Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 CAD | -2.78% | -11.39% | +20.69% |
Apr. 22 | XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal | MT |
Apr. 08 | XORTX Therapeutics Inc. Appoints Abigail Jenkins to the Board of Directors | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.37M 6.02M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 3 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.92% |
1 day | -2.78% | ||
1 week | -11.39% | ||
Current month | -30.00% | ||
1 month | -30.00% | ||
3 months | +8.36% | ||
6 months | -2.78% | ||
Current year | +20.69% |
Managers | Title | Age | Since |
---|---|---|---|
Allen Davidoff
FOU | Founder | 64 | 18-01-08 |
Jim Fairbairn
DFI | Director of Finance/CFO | 65 | 18-11-05 |
Stephen Haworth
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul van Damme
BRD | Director/Board Member | - | 18-01-24 |
Allen Davidoff
FOU | Founder | 64 | 18-01-08 |
Chairman | 67 | 22-06-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 3.5 | -2.78% | 5,885 |
24-04-29 | 3.6 | -11.55% | 11,620 |
24-04-26 | 4.07 | +12.43% | 9,937 |
24-04-25 | 3.62 | -8.35% | 6,008 |
24-04-24 | 3.95 | -.--% | 7,996 |
Delayed Quote Toronto S.E., April 30, 2024 at 03:55 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.69% | 7.64M | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- XRTX Stock